Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 16, Issue 3, 2009, Pages 292-299

  Tashiro, Seiki ^a,b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers   (Japan)

Author keywords

Heat shock protein; Liver regeneration; Portal vein branch embolization (ligation, occlusion); Tumor growth

Indexed keywords

ACTIVIN; ACTIVIN BETAA; ACTIVIN BETAC; ACTIVIN BETAE; ACTIVIN RECEPTOR; FOLLISTATIN; HEAT SHOCK PROTEIN 70; MESSENGER RNA; TEPRENONE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

DNA SYNTHESIS; DRUG EFFICACY; EXPERIMENTAL SURGERY; GENE EXPRESSION; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER REGENERATION; LIVER RESECTION; LIVER TUMOR; NONHUMAN; PORTAL VEIN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REVIEW; SAFETY; SURVIVAL RATE; TUMOR GROWTH; TUMOR VOLUME; VEIN LIGATION;

ANIMALS; COHORT STUDIES; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; HEAT-SHOCK PROTEINS; HEPATECTOMY; HUMANS; LIGATION; LIVER NEOPLASMS; LIVER REGENERATION; PORTAL VEIN; PROGNOSIS; RABBITS; RATS; RATS, WISTAR; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 67349145906     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-009-0058-x     Document Type: Review

References (50)

1. Rous P, Larimore LD. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Ext Med. 1920;31:609-32.
2. Kraus GE, Beltran A. Effect of induced infarction on rat liver implanted with Walker carcinoma 256. Arch Surg. 1959;79:769-74.
3. Hirono T. Effect of segmental interruption of portal venous blood supply on implanted tumor in the liver of rats. Arch Jap Chir. 1964;33:526-59.
4. Kozaka S. Extensive hepatectomy in two stages: An experimental study. Arch Jap Chir. 1963;32:99-123.
5. Honjo I, Suzuki T, Ozawa K, Takasan H, Kitamura O, Ishikawa T. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg. 1975;130:296-302.
6. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery. 1990;107:521-7.
7. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal embolization for hepatocellular carcinoma. World J Surg. 1986;10:803-8.
8. Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuga T, et al. Resection for multiple metastatic liver tumors after portal embolization. Surgery. 1994;115:674-7.
9. Nagino M, Nimura Y, Kamiya J. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for bile duct carcinoma. Surgery. 1995;117:677-81.
10. Wakabayashi H, Okada S, Maeba T, Maeta H. Effect of preoperative portal vein embolization on major hepatectomy for advanced stage hepatocellular carcinoma. Surg Today. 1997;27:403-10.
11. Shimada H, Endo I, Takahashi T, Togo S. Pathophysiology of major hepatic resection and benefits of preoperative portal embolization in preventing hepatic failure. J Hep Bil Pancr Surg. 1997;4:384-90.
12. Ishikawa M, Yogita S, Iuchi M, Yagi K, Chikaishi H, Fukuda Y, et al. Experimental and clinical studies on liver regeneration following transcatheter portal embolization. Hepatogastroenterology. 2000;47:226-33.
13. Tanaka M. Experimental study on tumor growth in the regenerating liver (in Japanese with English abstract). Nippon Geka Gakkai Zassi (J Jap Surg Soc). 1988;89:39-44.
14. De Jong KP, Brouwers MA, Hulus GA, Dam A, Bun JC, Wubbena AS, et al. Liver cell proliferation after hepatectomy in rats with liver metastases. Anal Quant Cytol Histol. 1997;20:59-68.
15. Mizutani J, Hiraoka T, Yamashita R, Miyauchi Y. Promotion of hepatic metastases by liver resection in the rat. Br J Cancer. 1992;65:794-7.
16. Iuchi M, Ishikawa M, Tashiro S (in press) Growth inhibition of experimental liver metastasis by portal embolization. Hepatogastroenterology
17. Matsui O, Takashima T, Kadoya M, Kitagawa K, Kamimura R, Itoh H, et al. Segmental staining on hepatic arteriography as a sign of intrahepatic portal vein obstruction. Radiology. 1984;152:601-6.
18. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, et al. Stimulation of liver growth by exogeneous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology. 1993;18:1443-9.
19. Russell WE, Coffey RJ, Ouellette AJ Jr, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA. 1988;85:5126-30.
20. Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rat. Gastroenterology. 1995;108:1136-42.
21. Fujii M, Ishikawa M, Iuchi M, Tashiro S. Effect of follistatin on rat liver regeneration and tumor growth after portal occlusion. Hepatogastroenterology. 2005;52:833-8.
22. Mellor SL, Cranfield M, Ries R, Pedersen J, Cancilla B, de Kretser D, et al. Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in human prostate and evidence for formation of new activin heterodimers of beta(C)-subunit. J Clin Endocrinol Metab. 2000;85:4851.
23. Vejda S, Cranfield M, Peter B, Mellor SL, Groome NP, Schulte-Hermann R, et al. Expression and dimerization of the rat activin subunits betaC and betaE: Evidence for the formation of novel activin dimmers. J Mol Endcrinol. 2002;28:137.
24. Hashimoto O, Tsuchida K, Ushiro Y, Hosoi Y, Hoshi N, Sugino H, et al. cDNA cloning and expression of human activin betaE subunit. Mol Cell Endocrinol. 2002;194:117.
25. Lau AL, Kumar TR, Nishimori K, Bonadio J, Matzuk MM. Activin betaC and betaE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol Cell Biol. 2000;20:6127.
26. Chabicovsky M, Herkner K, Rossmanith W. Overexpression of activin beta(C) or activin beta(E) in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of hepatic cells. Endocrinology. 2003;144:3497.
27. Esquela AF, Zimmers TA, Koniaris LG, Sitzmann JV, Lee SJ. Transient down-regulation of inhibin-betaC expression following partial hepatectomy. Biochem Biophys Res Commun. 1997;235:553.
28. Zhang YQ, Shibata H, Schrewe H, Kojima I. Reciprocal expression of mRNA for inhibin betaC and beta subunits in hepatocytes. Endocr J. 1997;44:759.
29. Mellor SL, Ball EM, O'Connor AE, Ethier JF, Cranfield M, Schmitt JF, et al. Activin betaC-subunit heterodimers provide anew mechanism of regulating activin levels in the prostate. Endocrinology. 2003;144:4410.
30. Takamura K, Tsuchida K, Miyake H, Tashiro S, Sugino H. Possible endocrine control by follistatin 315 during liver regeneration based on changes in the activin receptor after a partial hepatectomy in rats. Hepatogastroenterology. 2005;52:60-6.
31. Takamura K, Tsuchida K, Miyake H, Tashiro S, Sugino H. Activin activin receptor expression changes in liver regeneration in rat. J Surg Res. 2005;126:3-11.
32. Bellmann K, Wenz A, Radons J, Burkart V, Kleemann R, Kolb H. Heat-shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. J Clin Invest. 1995;95:2840-5.
33. Tissieres A, Mitchell HK, Tracy UM. Protein synthesis in salivary glands of Drosophila melanogaster. Relation to chromosome puffs. J Mol Biol. 1974;84:389-98.
34. Saad S, Kanai M, Awane M, et al. The protective effect of heat shock pretreatment with heat shock protein induction prior to hepatic warm ischemic injury caused by Pringle's maneuver. Surgery. 1995;118:510-6.
35. Shimabukuro T, Yamamoto Y, Kume M, Kimoto S, Okamoto R, Morimoto R, et al. Induction of heat shock response; effect on the rat liver with carbon tetrachloride-induced fibrosis from ischemia-reperfusion injury. Surgery. 1998;22:464-8.
36. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, et al. Ischemic preconditioning of the liver in rats; Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med. 1996;128:251-8.
37. Elias D, Desruennes E, Lasser P. Prolonged intermittent clamping of the portal triad during hepatectomy. Br J Surg. 1991;78:42-4.
38. Makuuchi M, Mori T, Gunven P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164:155-8.
39. Harada M, Yogita S, Tashiro S, Narioka J, Horiuchi M, Ohnishi T, et al. Effect of intermittent liver ischemia on outcome in patients with hepatocellular carcinoma on liver cirrhosis. J Med Invest. 1999;46:205-12.
40. Nagino M, Niura Y, Kamiya J, Kanai M, Uesaka K, Goto Y, et al. Preoperative transhepatic portal embolization for impaired residual hepatic function in patients with obstructive jaundice. J Hepatobiliary Pancreat Surg. 1997;4:373-6.
41. Kubo S, Kinoshita H, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, et al. Efficacy of preoperative portal embolization prior to major hepatectomy for patients with impaired liver function: A retrospective study. J Hepatobiliary Pancreat Surg. 1997;4:359-64.
42. Chijiwa K, Watanabe M, Hachiya Y, Kameoka N, Tanaka M. Serum Hyaluronic acid level reflects volume and ATP levels of the liver after extended hepatectomy with and without preoperative portal vein occlusion. J Surg Res. 1997;72:107-11.
43. Tanaka H, Ikeda K, Matsuyama M, Kubo S, Hirohashi K, Kinoshita H. Morphological and functional changes after portal vein occlusion in rats. J Hepatobiliary Pancreat Surg. 1997;4:365-72.
44. Nagano Y, Nagahori K, Kamiyama M, Fujii Y, Kubota T, Endo I, et al. Improved functional reserve of hypertrophied contralateral liver after portal vein ligation in rats. J Hepatol. 2002;37:72-7.
45. Miyake H, Fujii M, Sasaki K, Ando T, Ikeyama S, Iwata T, et al. Heat shock protein 70 induction in hepatocytes after right portal vein embolization. Hepatogastroenterology. 2003;50:2084-7.
46. Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology. 1996;111:345-57.
47. Yamagami T, Yamamoto Y, Ishikawa Y, Yonezawa K, Toyokuni S, Yamaoka Y. Effects of geranylgeranylacetone administration before heat shock preconditioning for conferring tolerance against ischemia-reperfusion injury in rat livers. J Lab Clin Med. 2000;135:465-75.
48. Fudaba Y, Tashiro H, Ohdan H, Miyata Y, Shibata S, Shintaku S, et al. Prevention of warm ischemic injury in rat liver transplantation by geranylgeranylacetone. Transplant Proc. 2000;32:1615-6.
49. Ikeyama S, Kusumoto K, Miyake H, Rokutan K, Tashiro S. A non-toxic heat shock protein 70 inducer, geranylgeranylacetone, suppresses apoptosis of cultured rat hepatocytes caused by hydrogen peroxide and ethanol. J Hepatol. 2001;35:53-61.
50. Oda H, Miyake H, Iwata T, Kusumoto K, Rokutan K, Tashiro S. Geranylgeranylacetone suppresses inflammatory responses and improves survival after massive hepatectomy in rats. J Gastrointes Surg. 2002;6:464-72.